97 related articles for article (PubMed ID: 31029864)
1. Comprehensive expression-based isoform biomarkers predictive of drug responses based on isoform co-expression networks and clinical data.
Ma J; Wang J; Ghoraie LS; Men X; Chen R; Dai P
Genomics; 2020 Jan; 112(1):647-658. PubMed ID: 31029864
[TBL] [Abstract][Full Text] [Related]
2. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
Huang S; Hu P; Lakowski TM
BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
[TBL] [Abstract][Full Text] [Related]
3. Network-based approach to identify principal isoforms among four cancer types.
Ma J; Wang J; Ghoraie LS; Men X; Haibe-Kains B; Dai P
Mol Omics; 2019 Apr; 15(2):117-129. PubMed ID: 30720033
[TBL] [Abstract][Full Text] [Related]
4. Cancer network activity associated with therapeutic response and synergism.
Serra-Musach J; Mateo F; Capdevila-Busquets E; de Garibay GR; Zhang X; Guha R; Thomas CJ; Grueso J; Villanueva A; Jaeger S; Heyn H; Vizoso M; Pérez H; Cordero A; Gonzalez-Suarez E; Esteller M; Moreno-Bueno G; Tjärnberg A; Lázaro C; Serra V; Arribas J; Benson M; Gustafsson M; Ferrer M; Aloy P; Pujana MÀ
Genome Med; 2016 Aug; 8(1):88. PubMed ID: 27553366
[TBL] [Abstract][Full Text] [Related]
5. Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.
Liu R; Lv QL; Yu J; Hu L; Zhang LH; Cheng Y; Zhou HH
Breast Cancer Res Treat; 2015 Jun; 151(3):607-18. PubMed ID: 25981901
[TBL] [Abstract][Full Text] [Related]
6. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; Martínez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
[TBL] [Abstract][Full Text] [Related]
7. Identifying gene expression patterns associated with drug-specific survival in cancer patients.
Neary B; Zhou J; Qiu P
Sci Rep; 2021 Mar; 11(1):5004. PubMed ID: 33654134
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer.
Wang JJ; Huang YQ; Song W; Li YF; Wang H; Wang WJ; Huang M
Oncol Rep; 2019 Dec; 42(6):2572-2582. PubMed ID: 31638237
[TBL] [Abstract][Full Text] [Related]
9. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
10. Circular RNAs and their associations with breast cancer subtypes.
Nair AA; Niu N; Tang X; Thompson KJ; Wang L; Kocher JP; Subramanian S; Kalari KR
Oncotarget; 2016 Dec; 7(49):80967-80979. PubMed ID: 27829232
[TBL] [Abstract][Full Text] [Related]
11. Predicting response to preoperative chemotherapy agents by identifying drug action on modeled microRNA regulation networks.
Zhu L; Liu J; Liang F; Rayner S; Xiong J
PLoS One; 2014; 9(5):e98140. PubMed ID: 24848634
[TBL] [Abstract][Full Text] [Related]
12. Dynamic genome and transcriptional network-based biomarkers and drugs: precision in breast cancer therapy.
Kyrochristos ID; Ziogas DE; Roukos DH
Med Res Rev; 2019 May; 39(3):1205-1227. PubMed ID: 30417574
[TBL] [Abstract][Full Text] [Related]
13. A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer.
Nam S; Chang HR; Jung HR; Gim Y; Kim NY; Grailhe R; Seo HR; Park HS; Balch C; Lee J; Park I; Jung SY; Jeong KC; Powis G; Liang H; Lee ES; Ro J; Kim YH
Cancer Lett; 2015 Jan; 356(2 Pt B):880-90. PubMed ID: 25449779
[TBL] [Abstract][Full Text] [Related]
14. Gene isoforms as expression-based biomarkers predictive of drug response in vitro.
Safikhani Z; Smirnov P; Thu KL; Silvester J; El-Hachem N; Quevedo R; Lupien M; Mak TW; Cescon D; Haibe-Kains B
Nat Commun; 2017 Oct; 8(1):1126. PubMed ID: 29066719
[TBL] [Abstract][Full Text] [Related]
15. RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model.
Jardim-Perassi BV; Alexandre PA; Sonehara NM; de Paula-Junior R; Reis Júnior O; Fukumasu H; Chammas R; Coutinho LL; Zuccari DAPC
Sci Rep; 2019 Jan; 9(1):966. PubMed ID: 30700756
[TBL] [Abstract][Full Text] [Related]
16. Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines.
Li Y; Umbach DM; Krahn JM; Shats I; Li X; Li L
BMC Genomics; 2021 Apr; 22(1):272. PubMed ID: 33858332
[TBL] [Abstract][Full Text] [Related]
17. A New Approach to Deriving Prognostic Gene Pairs From Cancer Patient-Specific Gene Correlation Networks.
Park B; Lee W; Han K
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(3):1267-1276. PubMed ID: 32809942
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer.
Li Y; Guo M; Fu Z; Wang P; Zhang Y; Gao Y; Yue M; Ning S; Li D
Oncotarget; 2017 Jan; 8(2):2444-2456. PubMed ID: 27911271
[TBL] [Abstract][Full Text] [Related]
20. Screening of Prognostic Factors in Early-Onset Breast Cancer.
Yu Z; He Q; Xu G
Technol Cancer Res Treat; 2020; 19():1533033819893670. PubMed ID: 32028860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
